Novo Nordisk

Latest articles

5d
NFL.com
Falcons aim to forget Super Bowl loss with Navy SEAL approachwho loves to pick the brains of colleagues in other sports, was out riding one
NFL.com / Posted 5 days ago
who loves to pick the brains of colleagues in other sports, was out riding one day with Phil Southerland, the CEO of Team Novo Nordisk, a pro cycling team composed of diabetic riders. Southerland told his friend about his team's work with Acumen... Read more
5d
Business Wire
TransCelerate BioPharma Grows Industry Collaborationsince the inception of TransCelerate include Allergan, Inc., Amgen, Astellas Ph
Business Wire / Posted 5 days ago
since the inception of TransCelerate include Allergan, Inc., Amgen, Astellas Pharma Inc., EMD Serono, Inc. (a subsidiary of Merck KGaA, Darmstadt, Germany), Merck & Co., Inc., Novartis International AG, Novo Nordisk, Shionogi & Co., Ltd.... Read more
7d
Arkansas Democrat-Gazette
Drug firm bets $40M to recruit new CEOshareholder value these guys can bring," he said. Before Lundbeck, Schultz spe
Arkansas Democrat-Gazette / Posted 7 days ago
shareholder value these guys can bring," he said. Before Lundbeck, Schultz spent more than 20 years climbing the ranks of Novo Nordisk, the world's biggest maker of insulin, eventually holding the role of chief operating officer as the drugmaker... Read more
4 related articles
8d
Boston Globe
With $40 million pay, Teva breaks from custom for turnaroundon Monday as investors welcomed the appointment. Prior to Lundbeck, Schultz spe
Boston Globe / Posted 8 days ago
on Monday as investors welcomed the appointment. Prior to Lundbeck, Schultz spent more than 20 years climbing the ranks of Novo Nordisk A/S, the world’s biggest maker of insulin, eventually holding the role of chief operating officer as the drug... Read more
4 related articles
8d
FOX Business
Why Teva Pharmaceutical Industries Ltd. ( Is Soaringindustry veteran with more than 30 years of experience who has held leading pos
FOX Business / Posted 8 days ago
industry veteran with more than 30 years of experience who has held leading positions at pharma companies like Lundbeck and Novo Nordisk. He will be taking over from Teva's current interim CEO, Dr. Yitzhak Peterburg, once his family officially... Read more
3 related articles
8d
FOX Business
Why Teva Pharmaceutical Industries Ltd. ( Is Soaringindustry veteran with more than 30 years of experience who has held leading pos
FOX Business / Posted 8 days ago
industry veteran with more than 30 years of experience who has held leading positions at pharma companies like Lundbeck and Novo Nordisk. He will be taking over from Teva's current interim CEO, Dr. Yitzhak Peterburg, once his family officially... Read more
3 related articles
8d
Reuters
Drugmaker Teva hires Lundbeck CEO Schultz to restore its healthAnd, he has significant credibility with stakeholders,” Barer said. Schultz be
Reuters / Posted 8 days ago
And, he has significant credibility with stakeholders,” Barer said. Schultz became Lundbeck CEO in May 2015 after leaving Novo Nordisk (NOVOb.CO) and the Danish firm’s share price has more than tripled since he returned it to profit by slimming... Read more
3 related articles
8d
Philly.com
Teva Pharmaceutical Industries names a new CEOnews. Schultz is currently president and CEO of Denmark’s H. Lundbeck A/S. Bef
Philly.com / Posted 8 days ago
news. Schultz is currently president and CEO of Denmark’s H. Lundbeck A/S. Before that, he was chief operating officer of Novo Nordisk. He will be based in Israel, at Teva’s headquarters in Petah Tikva. Teva had been without a permanent CEO since... Read more
4 related articles
8d
Market Watch
Teva names Lundbeck's Kare Schultz as new CEOjoins from Denmark's H. Lundbeck A/S, where he was president and CEO. He has al
Market Watch / Posted 8 days ago
joins from Denmark's H. Lundbeck A/S, where he was president and CEO. He has also worked a chief operating officer of Novo Nordisk A/S. Teva, the world's biggest seller of generic drugs, has been searching for a new permanent chief executive... Read more
8d
Business Wire
Teva Names Kåre Schultz as President and Chief Executive Officerand earnings. Prior to his role as President and CEO of H. Lundbeck A/S, Mr. Sh
Business Wire / Posted 8 days ago
and earnings. Prior to his role as President and CEO of H. Lundbeck A/S, Mr. Shultz served as Chief Operating Officer of Novo Nordisk, where he had a key role in building the company into one of the world’s best-performing drugmakers and... Read more
3 related articles
13d
FOX Business
7 Medical Conditions That Will Be Lining Big Pharma's Pockets by 2020that there were 422 million patients across the world with diabetes three years
FOX Business / Posted 13 days ago
that there were 422 million patients across the world with diabetes three years ago. The number is probably higher now. Novo Nordisk currently claims the greatest market share in the diabetes market, with combined sales of its products totaling... Read more
13d
FOX Business
7 Medical Conditions That Will Be Lining Big Pharma's Pockets by 2020that there were 422 million patients across the world with diabetes three years
FOX Business / Posted 13 days ago
that there were 422 million patients across the world with diabetes three years ago. The number is probably higher now. Novo Nordisk currently claims the greatest market share in the diabetes market, with combined sales of its products totaling... Read more
13d
WFMZ Eastern Pennsylvania and Western New Jersey
Danish drugmaker reaches settlement with US authoritiesCOPENHAGEN, Denmark (AP) - Danish drug maker Novo Nordisk says it has reached a
WFMZ Eastern Pennsylvania and Western New Jersey / Posted 13 days ago
COPENHAGEN, Denmark (AP) - Danish drug maker Novo Nordisk says it has reached a $46.5 million settlement with U.S. authorities over allegations that it hadn't properly communicated safety information when marketing a medicine to treat type 2... Read more
10 related articles
13d
Daily Herald
Danish drugmaker reaches settlement with US authoritiesCOPENHAGEN, Denmark -- Danish drug maker Novo Nordisk says it has reached a $46
Daily Herald / Posted 13 days ago
COPENHAGEN, Denmark -- Danish drug maker Novo Nordisk says it has reached a $46.5 million settlement with U.S. authorities over allegations that it hadn't properly communicated safety information when marketing a medicine to treat type 2... Read more
10 related articles
13d
FOX Business
Danish drugmaker reaches settlement with US authoritiesDanish drug maker Novo Nordisk says it has reached a $46.5 million settlement w
FOX Business / Posted 13 days ago
Danish drug maker Novo Nordisk says it has reached a $46.5 million settlement with U.S. authorities over allegations that it hadn't properly communicated safety information when marketing a medicine to treat type 2 diabetes. Novo Nordisk says it... Read more
10 related articles
13d
FOX Business
Danish drugmaker reaches settlement with US authoritiesCOPENHAGEN, Denmark – Danish drug maker Novo Nordisk says it has reached a $46.
FOX Business / Posted 13 days ago
COPENHAGEN, Denmark – Danish drug maker Novo Nordisk says it has reached a $46.5 million settlement with U.S. authorities over allegations that it hadn't properly communicated safety information when marketing a medicine to treat type 2... Read more
10 related articles
13d
WFTV 9 Orlando
Danish drugmaker reaches settlement with US authoritiesCOPENHAGEN, Denmark (AP) - Danish drug maker Novo Nordisk says it has reached a
WFTV 9 Orlando / Posted 13 days ago
COPENHAGEN, Denmark (AP) - Danish drug maker Novo Nordisk says it has reached a $46.5 million settlement with U.S. authorities over allegations that it hadn't properly communicated safety information when marketing a medicine to treat type 2... Read more
14d
Channel NewsAsia
Novo Nordisk settles US probe over diabetes drug for nearly US$58.7 millionREUTERS: Novo Nordisk will pay nearly US$58.7 million to resolve claims the dru
Channel NewsAsia / Posted 14 days ago
REUTERS: Novo Nordisk will pay nearly US$58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of U.S. Food and Drug Administration-mandated warnings about the cancer risks of its diabetes medication Victoza. The U.S.... Read more
10 related articles
14d
Reuters
Novo Nordisk settles U.S. probe over diabetes drug for nearly $58.7 million(Reuters) - Novo Nordisk will pay nearly $58.7 million to resolve claims the dr
Reuters / Posted 14 days ago
(Reuters) - Novo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker’s sales staff downplayed the importance of a warning about cancer risks on the label of its diabetes medication Victoza, the U.S. Justice Department said on... Read more
10 related articles
14d
FOX Business
Novo Nordisk settles U.S. probe over diabetes drug for nearly $58.7 millionNovo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sa
FOX Business / Posted 14 days ago
Novo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of a warning about cancer risks on the label of its diabetes medication Victoza, the U.S. Justice Department said on Tuesday. Continue... Read more
10 related articles
14d
FOX Business
Novo Nordisk settles U.S. probe over diabetes drug for nearly $58.7 millionNovo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sa
FOX Business / Posted 14 days ago
Novo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker's sales staff downplayed the importance of a warning about cancer risks on the label of its diabetes medication Victoza, the U.S. Justice Department said on Tuesday. The... Read more
10 related articles
14d
Reuters
Novo Nordisk settles U.S. probe over diabetes drug for $58.7 million(Reuters) - Novo Nordisk (NOVOb.CO) will pay $58.7 million to resolve claims th
Reuters / Posted 14 days ago
(Reuters) - Novo Nordisk (NOVOb.CO) will pay $58.7 million to resolve claims that the drugmaker’s sales staff downplayed the importance of a warning about cancer risks on its diabetes medication Victoza’s label, the U.S. Justice Department said on... Read more
10 related articles
14d
FOX Business
Novo Nordisk settles U.S. probe over diabetes drug for $58.7 milNovo Nordisk will pay $58.7 million to resolve claims that the drugmaker's sale
FOX Business / Posted 14 days ago
Novo Nordisk will pay $58.7 million to resolve claims that the drugmaker's sales staff downplayed the importance of a warning about cancer risks on its diabetes medication Victoza's label, the U.S. Justice Department said on Tuesday. (Reporting by... Read more
10 related articles
14d
FOX Business
Novo Nordisk settles U.S. probe over diabetes drug for $58.7 milNovo Nordisk will pay $58.7 million to resolve claims that the drugmaker's sale
FOX Business / Posted 14 days ago
Novo Nordisk will pay $58.7 million to resolve claims that the drugmaker's sales staff downplayed the importance of a warning about cancer risks on its diabetes medication Victoza's label, the U.S. Justice Department said on Tuesday. Continue... Read more
10 related articles
14d
Business Wire
Adocia annonce deux présentations à l’occasion du 53ème congrès annuel de l’Association Européenne pour l’Etude du Diabète (EASD)leaders parmi les agonistes de récepteur au GLP-1 (“GLP-1”) : dulaglutide (Trul
Business Wire / Posted 14 days ago
leaders parmi les agonistes de récepteur au GLP-1 (“GLP-1”) : dulaglutide (Trulicity®, Eli Lilly) ou liraglutide (Victoza®, Novo Nordisk). Le présent poster démontre que la technologie propriétaire BioChaperone® permet de solubiliser l’insuline... Read more
261 related articles
14d
Business Wire
Adocia Announces Two Data Presentations at the 53rd Annual Meeting of the European Association for the Study of DiabetesSanofi) with leading GLP-1 receptor agonists (“GLP-1”) dulaglutide (Trulicity®,
Business Wire / Posted 14 days ago
Sanofi) with leading GLP-1 receptor agonists (“GLP-1”) dulaglutide (Trulicity®, Eli Lilly) or liraglutide (Victoza®, Novo Nordisk). The present poster demonstrates that the proprietary BioChaperone® technology enables solubilization of... Read more
14d
Daily Echo
Dietician becomes diabetes champion to help transform carecan do no harm.” The award-winning Clinical Champions programme was launched b
Daily Echo / Posted 14 days ago
can do no harm.” The award-winning Clinical Champions programme was launched by Diabetes UK in 2014, in partnership with Novo Nordisk. There are now 65 champions across the UK. who have access to a network of like-minded clinicians with who they... Read more
15d
Business Wire
India Peptides and Heparin (Insulin, Teriparatide, Liraglutide, Leuprolide, Leuprolide, Exenatide, Calcitonin, Enaxaparin Sodium, Heparin Sodium) Market 2017to players in the Indian peptides market. For example, Victorza is the brand na
Business Wire / Posted 15 days ago
to players in the Indian peptides market. For example, Victorza is the brand name of the liraglutide peptide developed by Novo Nordisk. Its patent will expire in August 2017, which will enable drug manufacturers to introduce their generic versions... Read more
22d
Zero Hedge
Futures Flat As Gasoline Soars On Harvey Devastation, Rising Euro Sends European Stocks Lowerwere among the big losers in the Stoxx Europe 600 Index. European outperformers
Zero Hedge / Posted 22 days ago
were among the big losers in the Stoxx Europe 600 Index. European outperformers include Bolsas y Mercados Espanoles +0.9%, Novo Nordisk +0.8%, Steinhoff International Holdin +0.8%, Swiss Prime Site AG +0.7%, Michelin +0.7%, Aryzta AG +0.7%.... Read more
25d
Channel NewsAsia
FDA clears Novo Nordisk's diabetes drug to treat heart diseasesREUTERS: Novo Nordisk said on Friday the U.S. Food and Drug Administration (FDA
Channel NewsAsia / Posted 25 days ago
REUTERS: Novo Nordisk said on Friday the U.S. Food and Drug Administration (FDA) approved its diabetes drug as a treatment to reduce the risk of three major cardiovascular diseases. This is the first time the FDA has cleared a diabetes drug to treat... Read more
25d
Canberra Times
Phoenix Cycling Collective's Lauren Thomas prepares for National Road SeriesNew South Wales road champion for this year." Phoenix is being represented by
Canberra Times / Posted 25 days ago
New South Wales road champion for this year." Phoenix is being represented by a men's team with Sam Hill, Nathan Booth, Toby Stewart, William Barker, Kelsey Boreham, Andrew McCosker and guest rider Sam Munday from USA development team Novo Nor... Read more
3 related articles
25d
The North West Star
Canberra's 'superstar in the making' nears NRS debutNew South Wales road champion for this year." Phoenix is being represented by
The North West Star / Posted 25 days ago
New South Wales road champion for this year." Phoenix is being represented by a men's team with Sam Hill, Nathan Booth, Toby Stewart, William Barker, Kelsey Boreham, Andrew McCosker and guest rider Sam Munday from USA development team Novo Nor... Read more
3 related articles
25d
Sydney Morning Herald
Phoenix Cycling Collective's Lauren Thomas prepares for National Road SeriesNew South Wales road champion for this year." Phoenix is being represented by
Sydney Morning Herald / Posted 25 days ago
New South Wales road champion for this year." Phoenix is being represented by a men's team with Sam Hill, Nathan Booth, Toby Stewart, William Barker, Kelsey Boreham, Andrew McCosker and guest rider Sam Munday from USA development team Novo Nor... Read more
3 related articles
25d
The Age
Phoenix Cycling Collective's Lauren Thomas prepares for National Road SeriesNew South Wales road champion for this year." Phoenix is being represented by
The Age / Posted 25 days ago
New South Wales road champion for this year." Phoenix is being represented by a men's team with Sam Hill, Nathan Booth, Toby Stewart, William Barker, Kelsey Boreham, Andrew McCosker and guest rider Sam Munday from USA development team Novo Nor... Read more
3 related articles
26d
Daily Mirror
People with diabetes warned about faulty insulin penscleaning agents. People using the devices from affected batches, identified by
Daily Mirror / Posted 26 days ago
cleaning agents. People using the devices from affected batches, identified by their serial numbers should contact Novo Nordisk to replace the holder. John Wilkinson, MHRA'S Director of Medical Devices said: "This is a company-led recall... Read more
m
Newsmax
Diabetes Drug Succeeds in Key TrialNovo Nordisk A/S said on Wednesday its diabetes drug met the main goal of reduc
Newsmax / Posted 1 months ago
Novo Nordisk A/S said on Wednesday its diabetes drug met the main goal of reducing glucose levels in patients in a key late-stage trial, setting the stage for it to become the new standard therapy for type 2 diabetes. The 40-week trial tested two... Read more

In this news